4//SEC Filing
Prunty John D 4
Accession 0001104659-06-001044
CIK 0001013351other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:51 PM ET
Size
19.9 KB
Accession
0001104659-06-001044
Insider Transaction Report
Form 4
Prunty John D
Chief Financial Officer
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2006-01-04−5,000→ 0 totalExercise: $2.86Exp: 2012-11-20→ Common Stock (5,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2006-01-04−100,000→ 0 totalExercise: $2.30Exp: 2014-10-19→ Common Stock (100,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2006-01-04−15,000→ 0 totalExercise: $5.05Exp: 2011-09-10→ Common Stock (15,000 underlying) - Disposition to Issuer
Common Stock
2006-01-04−4,042→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2006-01-04−50,000→ 0 totalExercise: $1.77Exp: 2015-03-08→ Common Stock (50,000 underlying)
Footnotes (13)
- [F1]Disposed of pursuant to an Agreement and Plan of Merger among issuer, EpiCept Corporation and Magazine Acquisition Corp., dated September 6, 2005, in exchange for 0.203969 shares of EpiCept common stock and cash for fractional shares of EpiCept common stock equal to approximately $1.134 per share. Because there was no public market for the EpiCept common stock at the effective time of the merger, the market value of such stock was not determinable.
- [F10]The option vests 25% per year over 4 years.
- [F11]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 3,059 shares of EpiCept common stock for $24.76 per share.
- [F12]The option vests 25% per year over 4 years.
- [F13]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 1,019 shares of EpiCept common stock for $28.54 per share.
- [F2]The option vests 25% per year over 4 years.
- [F3]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 1,019 shares of EpiCept common stock for $14.03 per share.
- [F4]The option vests 25% per year over 4 years.
- [F5]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 1,019 shares of EpiCept common stock for $32.95 per share.
- [F6]The option vests 25% per year over 4 years.
- [F7]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 20,396 shares of EpiCept common stock for $11.28 per share.
- [F8]The option vests 100% over 6 months.
- [F9]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 10,198 shares of EpiCept common stock for $8.68 per share.
Documents
Issuer
MAXIM PHARMACEUTICALS INC
CIK 0001013351
Entity typeother
Related Parties
1- filerCIK 0001306376
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 6:51 PM ET
- Size
- 19.9 KB